All diseases

Disease Atlas / Disease detail

Wilson disease

An atlas of ATP7B-related copper accumulation, hepatic, neurologic and psychiatric disease, diagnosis, and lifelong treatment.

Wilson disease · hepatolenticular degeneration

MONDO:0010200Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 0d7f4a73ec5c

Disease class
Wilson disease is an inherited copper-accumulation disorder.
Core mechanism
Biallelic ATP7B variants cause this recessive disorder.
Genes or cause
Copper accumulates mainly in liver, brain, and cornea.
Typical features
Hepatitis, cirrhosis, or acute liver failure can occur.
Variability
Movement and psychiatric manifestations can occur.
Diagnosis
Diagnosis integrates multiple clinical and biochemical findings.
Management
Ceruloplasmin alone cannot establish diagnosis.
Treatment and research
Urine copper, eye examination, and genetics complement diagnosis.
Reading evidence
Chelators or zinc are used lifelong.
Key caution
Treatment is individualized to limit neurologic worsening.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Wilson disease is an inherited copper-accumulation disorder.

Hepatitis, cirrhosis, or acute liver failure can occur.

How the disease works

Biallelic ATP7B variants cause this recessive disorder.

Copper accumulates mainly in liver, brain, and cornea.

Why experiences vary

Movement and psychiatric manifestations can occur.

Diagnosis and management

Diagnosis integrates multiple clinical and biochemical findings.

Treatment status

Ceruloplasmin alone cannot establish diagnosis.

Urine copper, eye examination, and genetics complement diagnosis.

Reading clinical trials

Liver, neurologic status, and copper markers are monitored.

Topics for a clinical visit

Family testing and treatment adherence require review.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.